| Tyra Everett Rios, MFT | |
|
2268 Mayport Rd # F, Jacksonville, FL 32233-6398 | |
| (805) 236-1260 | |
| Not Available |
| Full Name | Tyra Everett Rios |
|---|---|
| Gender | Female |
| Speciality | Marriage & Family Therapist |
| Location | 2268 Mayport Rd # F, Jacksonville, Florida |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679153068 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | (Florida) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Tyra Everett Rios, MFT 2392 Edgewood Ave N, Jacksonville, FL 32254-1725 Ph: (805) 236-1260 | Tyra Everett Rios, MFT 2268 Mayport Rd # F, Jacksonville, FL 32233-6398 Ph: (805) 236-1260 |
News Archive
New research reveals that telephone-based peer support may help reduce postnatal depression, also known as postpartum depression, in new mothers. Findings published in the Journal of Advanced Nursing also found that social support from peers may be effective for maternal depression up to two years after delivery.
N30 Pharmaceuticals, Inc. announced today that it has begun oral dosing of N91115 in a Phase 1 clinical trial. N91115, a novel inhibitor of S-nitrosoglutathione reductase (GSNOR), is being developed for the treatment of cystic fibrosis (CF).
The American College of Preventive Medicine (ACPM) supports the recommendations of the US Preventive Services Task Force (USPSTF) that primary care providers should screen all adults for depression, and further recommends that all primary care providers should have systems in place to ensure the accurate diagnosis and treatment of this condition.
Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS) today announced that the United States Food and Drug Administration (FDA) has granted Orphan Drug Designation to Restanza(TM) (cethromycin), its novel, once daily oral antibiotic, for the prophylactic treatment of plague and tularemia. Both tularemia and plague are classified by the Centers for Disease Control as Category A Bioterrorism Agents, which is the highest priority classification.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced the launch of the ExoSeal(TM) Vascular Closure Device. ExoSeal(TM) incorporates a number of new advances in technology and simplicity of design to provide precise and secure extravascular arterial closure. Cordis Corporation received CE-Marking approval for ExoSeal(TM) Vascular Closure Device in May 2010.
› Verified 9 days ago
Dr. Tabitha Renee Johnson, PHD, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 2950 Halcyon Ln, Suite #605, Jacksonville, FL 32223 Phone: 904-302-5340 Fax: 904-800-1211 | |
Evelyn Huntley, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 12627 San Jose Blvd Ste 203, Jacksonville, FL 32223 Phone: 904-625-0596 | |
Lisa Jeanine Parker Miller, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 3027 San Diego Rd, Jacksonville, FL 32207 Phone: 904-493-7758 | |
Ms. Rachel Amanda Hirst, MS, NCC Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 4595 Lexington Ave, Jacksonville, FL 32210 Phone: 904-783-2579 | |
Philip David Justice, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 6251 Philips Hwy Ste 4, Jacksonville, FL 32216 Phone: 904-256-4904 | |
Laura Daniel, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 6817 Southpoint Pkwy Ste 1304, Jacksonville, FL 32216 Phone: 904-298-6946 | |
Angelus Martin, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 435 Clark Rd Ste 107, Jacksonville, FL 32218 Phone: 904-683-1425 |